Want to see HK:2162 full AI Analyst Report?

Keymed Biosciences, Inc. (2162) Revenue

1 Followers

Keymed Biosciences, Inc. Revenue

Keymed Biosciences, Inc. had a revenue of 608.55M in the quarter ending Jun 30, 2026, with 184.46%. This bring the company's revenue in the last twelve months to 822.48M, Decreased 15.41%. In the fiscal year ending Dec 31, 2025, Keymed Biosciences, Inc. had annual revenue of 697.77M with 62.98% growth.

Revenue (ttm)

822.48M

Revenue Growth

0.08%

P/S Ratio

32.81

Revenue/Employee

HK$394,669

Employees

1,768

Market Cap

HK$22.90B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	697.77M	269.65M	+62.98%
Dec 31, 2024	428.12M	74.03M	+20.91%
Dec 31, 2023	354.10M	254.03M	+253.87%
Dec 31, 2022	100.06M	-10.21M	-9.26%
Dec 31, 2021	110.27M	―	+∞%
Dec 31, 2020	―	―	―
Dec 31, 2019	―	―	―